|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Disorder of kidney due to diabetes mellitus | 09-Sep-2023 | active |
| Chronic kidney disease stage 1 | 09-Sep-2023 | active |
| Hyperglycemia | 22-Aug-2020 | active |
| Essential hypertension | 30-Jul-2016 | active |
| Metabolic syndrome X | 30-Jul-2016 | active |
| Hypertriglyceridemia | 30-Jul-2016 | active |
| Type 2 diabetes mellitus | 25-Jul-2015 | active |
| Osteoporosis | 14-Jun-2008 | active |
| Ischemic heart disease | 28-May-2005 | active |
| Sleep apnea | 13-Mar-1982 | active |
| Sleep disorder | 08-Feb-1982 | active |
| Anemia | 27-Apr-1963 | active |
| Acute bronchitis | 26-Jan-2024 - 04-Feb-2024 | inactive |
| Acute viral pharyngitis | 02-May-2017 - 15-May-2017 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Human isophane insulin 70 unit/mL and recombinant human regular insulin 30 unit/mL solution for injection | 2024-09-14 | - | Inject 10 units (70/30 insulin) subcutaneously once daily before breakfast | Diabetes mellitus type 2 (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2024-09-14 | - | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Metformin hydrochloride 500 mg prolonged-release oral tablet | 2024-09-14 | - | 1 tablet (500 mg) once daily | Diabetes mellitus type 2 (disorder) |
| Alendronic acid (as alendronate sodium) 10 mg oral tablet | 2024-09-14 | - | 1 tablet (10 mg) once daily | Osteoporosis (disorder) |
| Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2005-06-04 | - | 1 tablet (75 mg) once daily | - |
| Simvastatin 20 mg oral tablet | 2005-06-04 | - | 1 tablet (20 mg) by mouth once daily | - |
| Nitroglycerin 400 microgram/actuation sublingual spray | 2005-06-04 | - | 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | - |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2005-06-04 | - | 1 tablet (100 mg) once daily | - |
| Ferrous sulfate 325 mg prolonged-release oral tablet | 1963-05-04 | - | 1 tablet (325 mg) by mouth once daily | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 14-Sep-2024 |
| SARS-CoV-2 mRNA vaccine | 04-Dec-2021 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 17-Aug-2019 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Sleep apnea assessment | 03-Feb-2024 | Sleep disorder (disorder) |
| Depression screening | 03-Feb-2024 | - |
| Assessment of health and social care needs | 03-Feb-2024 | - |
| Assessment of anxiety | 03-Feb-2024 | - |
| Assessment using Morse Fall Scale | 03-Feb-2024 | - |
| Referral to home health care service | 23-Jul-2016 | - |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Lifestyle education regarding hypertension | 30-Jul-2016 | Essential hypertension (disorder) |
|
||
| Care plan | 13-Mar-1982 | Sleep apnea (disorder) |
|
||
| Diabetes self management plan | 23-Apr-1960 | Prediabetes (finding) |
|
||
| Immunization Recommendation | Due Date | Reason |
| Influenza virus antigen only vaccine product | 01-Oct-2026 | Annual seasonal influenza vaccination |
Vital Signs
| Vital Signs | 2024-09-14 | 2024-05-11 |
|---|---|---|
| Body Height | 178.5 cm | 178.5 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 3 {score} |
| Body Weight | 87.5 kg | 90.7 kg |
| Body mass index (BMI) [Ratio] | 27.5 kg/m2 | 28.5 kg/m2 |
| Heart rate | 79 /min | 65 /min |
| Respiratory rate | 14 /min | 13 /min |
| Blood pressure panel with all children optional | 95 mm[Hg] | 100 mm[Hg] |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 14-SEP-2024 | Reference Range | Unit |
|---|---|---|---|
| Glucose [Mass/volume] in Serum or Plasma | 67.1 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Serum or Plasma | 17.1 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Serum or Plasma | 1.8 H | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Serum or Plasma | 10.1 | 8.6 - 10.3 | mg/dL |
| Sodium [Moles/volume] in Serum or Plasma | 143.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Serum or Plasma | 4.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Serum or Plasma | 110.3 H | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Serum or Plasma | 23.5 | 22 - 29 | mmol/L |
| Appearance of Urine | Cloudy urine | ||
| Odor of Urine | Urine smell ammoniacal | ||
| Clarity of Urine | Translucent | ||
| Color of Urine | Brown color | ||
| Glucose [Mass/volume] in Urine by Test strip | 1.2 H | 0 - 0 | mg/dL |
| Glucose [Presence] in Urine by Test strip | Urine glucose test = ++ | ||
| Bilirubin.total [Mass/volume] in Urine by Test strip | 1.0 | 0 - 4 | mg/dL |
| Bilirubin.total [Presence] in Urine by Test strip | Finding of bilirubin in urine | ||
| Ketones [Mass/volume] in Urine by Test strip | 16.4 H | 0 - 4 | mg/dL |
| Ketones [Presence] in Urine by Test strip | Urine ketone test = trace | ||
| Specific gravity of Urine by Test strip | 1.0 L | 1.005 - 1.030 | {nominal} |
| pH of Urine by Test strip | 5.8 | 5.0 - 7.0 | pH |
| Protein [Mass/volume] in Urine by Test strip | 100.2 H | 0 - 20 | mg/dL |
| Protein [Presence] in Urine by Test strip | Urine protein test = + | ||
| Nitrite [Presence] in Urine by Test strip | Urine nitrite negative | ||
| Hemoglobin [Presence] in Urine by Test strip | Urine blood test = negative | ||
| Leukocyte esterase [Presence] in Urine by Test strip | Urine leukocyte test negative | ||
| Hemoglobin A1c/Hemoglobin.total in Blood | 2.4 L | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 67.1 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 17.1 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.9 | 0.7 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 10.1 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 143.5 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 110.3 H | 98 - 110 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 23.5 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 157.8 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 143.2 | 0 - 149 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 78.8 | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 50.4 | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 11.2 | 0 - 30 | mg/g |
Device Use
| Device | Date (since) |
|---|---|
| Home continuous positive airway pressure unit (physical object) | 03-Feb-2024 |
| Respiratory humidifier (physical object) | 03-Feb-2024 |
| Blood glucose meter (physical object) | 23-Apr-1960 |